![Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial - The Lancet Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/2a78ad47-17a7-4f32-9932-96ecbc741fed/gr1_lrg.gif)
Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial - The Lancet
![Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial - The Lancet Infectious Diseases Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/2005796654/2025321369/gr1.gif)
Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial - The Lancet Infectious Diseases
![Trattamento dell'infezione da virus dell'immunodeficienza umana (HIV) con antiretrovirali - Infezioni - Manuale MSD, versione per i pazienti Trattamento dell'infezione da virus dell'immunodeficienza umana (HIV) con antiretrovirali - Infezioni - Manuale MSD, versione per i pazienti](https://www.msdmanuals.com/-/media/manual/home/images/i/n/f/inf_hiv_drug_action_life_cycle_rev_2_it.gif?thn=0&sc_lang=it)